GBI International
NEW

PITDC Leads Delegation to Seek Opportunities in Pharmaceutical Manufacturing Hub in Germany
GBI International
NEW

Taiwan Pharmaceutical Alliance Engages at 2025 CPHI to Boost International Cooperation and Exports

GBI International
NEW

Spirit Scientific Wins Double Bronze for Regenerative Medicine Innovation at TIE 2025

GBI International
GBIHighlights

Dr. Yijuang Chern: Microglial Galectin-3 and Neuroinflammation...

2024-03-31/GlobalBio & Investment
#iPSCellRevolutionOnMarch11th(Mon.),StanfordUniversityfromtheU.S.,KaohsiungMedicalUniversity,andAcademiaSinicawilljointlyhostthe2024Stanford-TaiwanSymposiumoniPSCandRegenerativeMedicine.Inthisevent,Dr...
GBI International
GBIHighlights

Dr. Ying-Chih Chang: Harnessing Biomimetic Materials to Induce Stemness in Rare Cells for...

2024-03-31/GlobalBio & Investment
#iPSCellRevolutionOnMarch11th(Mon.),StanfordUniversityfromtheU.S.,KaohsiungMedicalUniversity,andAcademiaSinicawilljointlyhostthe2024Stanford-TaiwanSymposiumoniPSCandRegenerativeMedicine.????Inthiseven...
GBI International
GBIHighlights

Dr. Shihhwa Chiou: Application of iPSC-based Technology on Retinal Diseases

2024-03-31/GlobalBio & Investment
#iPSCellRevolutionOnMarch11th(Mon.),StanfordUniversityfromtheU.S.,KaohsiungMedicalUniversity,andAcademiaSinicawilljointlyhostthe2024Stanford-TaiwanSymposiumoniPSCandRegenerativeMedicine.????Inthiseven...
GBI International
GBIHighlights

Dr. Jun-An Chen: Conducting the Neuronal Molecular Symphony

2024-03-31/GlobalBio & Investment
#iPSCellRevolutionOnMarch11th(Mon.),StanfordUniversityfromtheU.S.,KaohsiungMedicalUniversity,andAcademiaSinicawilljointlyhostthe2024Stanford-TaiwanSymposiumoniPSCandRegenerativeMedicine.Inthisevent,Dr...
GBI International
GBIHighlights

Dr. Patrick Hsieh: Taiwan iPSC Bank for precision medicine and cell therapy

2024-03-31/GlobalBio & Investment
#iPSCellRevolutionOnMarch11th(Mon.),StanfordUniversityfromtheU.S.,KaohsiungMedicalUniversity,andAcademiaSinicawilljointlyhostthe2024Stanford-TaiwanSymposiumoniPSCandRegenerativeMedicine.Inthisevent,Dr...
GBI International
GBIHighlights

Make a Wild Horse into a Pegasus! iPS Cells Research in Taiwan – List of Scientists!

2024-03-31/GlobalBio & Investment
#iPSCellRevolutionThe#iPSCellRevolutionsignifiestherevolutionarydiscoveryofinducedpluripotentstemcells(iPScells)byDr.ShinyaYamanaka(山中伸弥)in2006.Sincethen,scientistsworldwidehavebeenworkinghardtoexplor...
GBI International
GBIHighlights

Formosa Pharmaceuticals, Inc. has received FDA approval for their ophthalmic eye drops

2024-03-31/GlobalBio & Investment
#FDAApprovalExcitingnews!FormosaPharmaceuticals,Inc.(6838.TWO)hasreceivedFDAapprovalfortheirhashtag#ophthalmiceyedrops,APP13007,whichareusedtotreatpost-operativeinflammationandpainfollowingeyesurgery....
GBI International
GBIHighlights

Taiwan’s research and development of rare disease drugs has yielded great results!

2024-03-31/GlobalBio & Investment
#RareDiseaseBreakthroughsAmidstthepandemic,Taiwanesepharmaceuticalcompaniesdevelopingrarediseasedrugshavereportedpositiveresultsinclinicaltrials,leadingtoremarkablegrowthintheirstocks.Over30companiesi...
GBI International
GBIHighlights

BRIM Biotechnology, Inc. announced its three focus areas for this year's operations

2024-02-28/GlobalBio & Investment
#OphthalmologyInnovationGreatnewsfromBRIMBiotechnology,Inc.(6885.TWO)!Thecompanyhasannounceditsthreefocusareasforthisyear'soperations,whichinclude:1.ContinuingthedevelopmentofBRM421,theirleadasset...
GBI International
GBIHighlights

Sartorius experts highlighted the key specifications of the new PIC/S GMP Annex 1 regulation

2024-02-28/GlobalBio & Investment
#BiotechInsightsExcitingupdatesfromSartoriusandAdimmuneCorp(4142)'scorporateseminar!Sartoriusexperts,Tse-WeiChenandRZLin,highlightedthelatesttrendsincellculturedevelopmentandthekeyspecificationsof...
GBI International
GBIHighlights

AnHorn partnered with European startups to explore new treatment targets for prostate cancer

2024-02-28/GlobalBio & Investment
#InnovativeCollaborationAnHornMedicines,anAI-drivendrugdiscoverycompanyfocusedonproteindegradation,haspartneredwithEuropeanstartupstoexplorenewtreatmenttargetsforprostatecancer.On20February2024,Anhorn...
GBI International
GBIHighlights

PharmaEssentia and Oneness Biotech Co Ltd have been honored in Sustainability Yearbook 2024

2024-02-28/GlobalBio & Investment
#ESGExcellenceExcitingnews!PharmaEssentia(TPE:6446)andOnenessBiotechCoLtd(TPE:4743)havebeenhonoredintheprestigiousSustainabilityYearbook2024byS&PGlobalRatings.PharmaEssentiamarksahistoricmomentast...

TOP
  • Global Bio and Investment Monthly
  • 讀者服務電話：+886 2 2726 1065時間：週一 ~ 週五 09:00 ~ 18:00
  • 服務信箱：[email protected]
  • 地址：110臺北市信義區信義路六段29號2樓之一, Taiwan

我們的服務